NDAORALCAPSULE, EXTENDED RELEASE
Approved
Jan 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Data completeness
3/8 — Basic
DIAMOX (acetazolamide) by Teva is clinical pharmacology acetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (eg, some types of glaucoma), in the treatment of certain convulsive disorders (eg, epilepsy) and in the promotion of diuresis in instances of abnormal fluid retention (eg, cardiac edema). First approved in 1962.
Drug data last refreshed 18h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DIAMOX (acetazolamide) is a potent carbonic anhydrase inhibitor approved in 1962 for glaucoma, epilepsy, edema, and acute mountain sickness prevention. It works by inhibiting the enzyme carbonic anhydrase, reducing aqueous humor secretion in the eye, stabilizing neuronal discharge in the CNS, and promoting diuresis through renal bicarbonate loss. The drug is available as an oral extended-release capsule.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30%), indicating a contracting team focus and shift toward generic defense or transition planning.
Mechanism of Action
CLINICAL PHARMACOLOGY Acetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (eg, some types of glaucoma), in the treatment of certain convulsive disorders (eg, epilepsy) and in the promotion of diuresis in instances of abnormal fluid retention (eg,…
Worked on DIAMOX at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.